Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Apr 18, 2016
NEW ORLEANS, April 18, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today presented the first proof-of-concept data from its novel multiplexed digital immunohistochemistry (IHC) technology at the American Association for Cancer ...
Apr 14, 2016
nCounter Vantage Products Enable Simultaneous Analysis of DNA, RNA, and Protein to Expand Capabilities In Cancer Research, Including Immuno-Oncology Multiple New Products to be Featured at the American Association for Cancer Research (AACR) 2016 Annual Meeting in New Orleans SEATTLE, April 14, 2016 (GLOBE NEWSWIRE) -- NanoString Technologi...
Apr 13, 2016
SEATTLE, April 13, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will release first quarter 2016 financial results after the close of trading on Thursday, May 5, 2016. Company management will host...
Apr 11, 2016
SEATTLE and MARSEILLE, France, April 11, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and HalioDx SAS, a diagnostic company in immuno-oncology, today announced they have entered into an agreement to jointly develop and commercia...
Mar 21, 2016
SEATTLE, March 21, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that Noridian Healthcare Solutions, LLC, a Medicare Administrative Contractor (MAC) for two Medicare jurisdictions covering 13 states, has issued fa...
Mar 10, 2016
SEATTLE and DANVERS, Mass., March 10, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and Cell Signaling Technology (CST), a worldwide provider of antibodies, have reached an agreement to use highly validated antibodies from CST in...
Feb 29, 2016
SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2015. Fourth Quarter Financial HighlightsTotal revenue of $22.3 million, 43% y...
Feb 29, 2016
SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a collaboration agreement with Merck, known as MSD outside the US and Canada, through a subsidiary, to develop and commercia...
Feb 22, 2016
SEATTLE, Feb. 22, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the Cowen and Company 36th Annual Health Care Conference in Boston. Brad Gray, Presiden...
Feb 12, 2016
SEATTLE, Feb. 12, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release fourth quarter 2015 financial results after the close of trading on Monday, February 29, 2016. Company management will ...
Feb 11, 2016
ORLANDO, Fla., Feb. 11, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today presented the first proof-of-concept data for its novel massively parallel single molecule sequencing chemistry, Hyb & SeqTM, at the Advances in Genome B...
Feb 9, 2016
SEATTLE, Feb. 09, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the updated American Society of Clinical Oncology (ASCO) Clinical Practice Guideline on the appropriate use of breast tumor biomarker assay resu...
Jan 27, 2016
SEATTLE, Jan. 27, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company's management is scheduled to present at the Leerink Partners 5th Annual Global Healthcare Conference in New York City. Brad Gra...
Jan 10, 2016
SEATTLE, Jan. 10, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the year ended December 31, 2015. Financial Highlights: Total revenue for 2015 expected to be ...
Jan 7, 2016
SAN FRANCISCO, CA and SEATTLE, WA--(Marketwired - Jan 7, 2016) - Medivation, Inc. (NASDAQ: MDVN) and NanoString Technologies, Inc., (NASDAQ: NSTG) today announced they have entered into a collaboration, together with Astellas Pharma Inc., to pursue the translation of a novel gen...
= add release to Briefcase